Cost implication of using Lorcaserin in Weight Management prior to Bariatric Surgery

Autor:	R.L. Knoth, Z. Wang, Xuan Li, K. Fujioka
Rok vydání:	2015
Předmět:	medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Placebo medicine.disease Lorcaserin Surgery Weight loss Diabetes mellitus Weight management Medicine In patient medicine.symptom business medicine.drug
Zdroj:	Value in Health. 18(3)
ISSN:	1098-3015
DOI:	10.1016/j.jval.2015.03.1719
Popis:	Figure 2. Effect of (A) Lorcaserin and (B) Placebo on Weight Loss at 1 Year in Patients With Baseline BMI ≥40 kg/m Figure 3. Effect of (A) Lorcaserin and (B) Placebo on Weight Loss at 1 Year in Patients With Baseline BMI 35–39.9 kg/m T-P 3139 Cost Implication of Using Lorcaserin in Weight Management Prior to Bariatric Surgery Zhixiao Wang, Xuan Li, Russell Knoth, Ken Fujioka Eisai Inc., Woodcliff Lake, NJ, USA; Department of Diabetes and Endocrinology, Scripps Clinic, La Jolla, CA, USA
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b67771fccdbcc87daeb65c5230454436 Zobrazit plný text záznamu Full Text from ScienceDirect